Lipid abnormalities during ART: it's the drug, not the class.
D019380:Anti-HIV Agents / Q000009:adverse effects*; D017320:HIV Protease Inhibitors / Q000009:adverse effects; D006801:Humans; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy; D018579:Patient Selection; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors